Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 2/20 | 0.47 |
| ▸ | ADH1C | P00326 | 2/20 | 0.47 |
| ▸ | ADH1A | P07327 | 2/20 | 0.47 |
| ▸ | ADH4 | P08319 | 2/20 | 0.47 |
| ▸ | ADH7 | P40394 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 8/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8262455 | 1.00 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL26363864 | 0.98 | ALDH1A1 (0.43) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14230240 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL16450785 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL9209441 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL24104636 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL18546867 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL13762880 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL5011942 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL9205673 | 0.95 | ADH1B (0.52) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023208986-A1 | IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2023-11-02 | — | — | WO | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |